Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Polygenic risk scores mediating functioning outcomes through cognitive and clinical features in youth at family risk and controls.
Segura AG, Serna E, Sugranyes G, Baeza I, Valli I, Martínez-Serrano I, Díaz-Caneja CM, Andreu-Bernabeu Á, Moreno DM, Gassó P, Rodríguez N, Martínez-Pinteño A, Prohens L, Torrent C, García-Rizo C, Mas S, Castro-Fornieles J. Segura AG, et al. Among authors: martinez pinteno a. Eur Neuropsychopharmacol. 2024 Apr;81:28-37. doi: 10.1016/j.euroneuro.2024.01.009. Epub 2024 Feb 6. Eur Neuropsychopharmacol. 2024. PMID: 38310718 Free article.
Effects of the PAM of mGluR2, JNJ-46356479, on brain apoptotic protein levels in a mouse model of schizophrenia.
Olivares-Berjaga D, Martínez-Pinteño A, Rodríguez N, Madero S, Prohens L, Martínez-Serrano I, Mas S, Morén C, Parellada E, Gassó P. Olivares-Berjaga D, et al. Among authors: martinez pinteno a. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Apr 20;131:110955. doi: 10.1016/j.pnpbp.2024.110955. Epub 2024 Feb 1. Prog Neuropsychopharmacol Biol Psychiatry. 2024. PMID: 38296154 Free article.
Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic risk.
Prohens L, Rodríguez N, Segura ÀG, Martínez-Pinteño A, Olivares-Berjaga D, Martínez I, González A, Mezquida G, Parellada M, Cuesta MJ, Bernardo M, Gassó P, Mas S. Prohens L, et al. Among authors: martinez pinteno a. Psychiatry Res. 2024 Feb;332:115722. doi: 10.1016/j.psychres.2024.115722. Epub 2024 Jan 5. Psychiatry Res. 2024. PMID: 38198858 Free article.
Early treatment with JNJ-46356479, a mGluR2 modulator, improves behavioral and neuropathological deficits in a postnatal ketamine mouse model of schizophrenia.
Martínez-Pinteño A, Rodríguez N, Olivares D, Madero S, Gómez M, Prohens L, García-Rizo C, Mas S, Morén C, Parellada E, Gassó P. Martínez-Pinteño A, et al. Biomed Pharmacother. 2023 Feb;158:114079. doi: 10.1016/j.biopha.2022.114079. Epub 2022 Dec 14. Biomed Pharmacother. 2023. PMID: 36521250 Free article.
Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients.
Rodríguez N, Gassó P, Martínez-Pinteño A, Segura ÀG, Mezquida G, Moreno-Izco L, González-Peñas J, Zorrilla I, Martin M, Rodriguez-Jimenez R, Corripio I, Sarró S, Ibáñez A, Butjosa A, Contreras F, Bioque M, Cuesta MJ, Parellada M, González-Pinto A, Berrocoso E, Bernardo M, Mas S; 2EPS group. Rodríguez N, et al. Among authors: martinez pinteno a. Schizophrenia (Heidelb). 2022 Apr 27;8(1):45. doi: 10.1038/s41537-022-00215-1. Schizophrenia (Heidelb). 2022. PMID: 35853879 Free PMC article.
Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode.
Segura AG, Mezquida G, Martínez-Pinteño A, Gassó P, Rodriguez N, Moreno-Izco L, Amoretti S, Bioque M, Lobo A, González-Pinto A, García-Alcon A, Roldán-Bejarano A, Vieta E, de la Serna E, Toll A, Cuesta MJ, Mas S, Bernardo M; PEPs Group. Segura AG, et al. Among authors: martinez pinteno a. Psychol Med. 2023 Jul;53(10):4634-4647. doi: 10.1017/S0033291722001544. Epub 2022 Jun 9. Psychol Med. 2023. PMID: 35678455 Free PMC article.
21 results